ArticleFrontiers in oncology2025

Case Report: Accelerated parathyroid adenoma progression and hypercalcemia-driven neurotoxicity following pembrolizumab-based neoadjuvant therapy in triple-negative breast cancer: a case of multisystem immune-related adverse events.

Yi Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.